ArticleFrontiers in oncology2026
Gardner syndrome initially misdiagnosed as bilateral breast malignancy: a case report and literature review.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: To report a rare case of Gardner syndrome (GS) initially presenting with bilateral breast masses, emphasizing the diagnostic challenges of atypical manifestations and the importance of multidisciplinary collaboration. Methods: A retrospective analysis was conducted using clinical data, multimodal imaging (ultrasound, mammography, magnetic resonance imaging, and computed tomography), histopathological evaluation via core needle biopsy, and multidisciplinary team (MDT) consultation. Colonoscopy was performed to confirm systemic involvement. Results: A 27-year-old woman presented with bilateral breast masses that were initially suspected to be malignant. Imaging revealed irregular spiculated lesions mimicking invasive carcinoma. Histopathological examination confirmed the presence of fibromatosis in both breasts and the right interpectoral region. Systemic evaluation revealed craniofacial osteomas, subcutaneous/muscular soft tissue tumors, left adrenal adenoma, and multiple colorectal polyps (superficial serrated adenomas). MDT review confirmed GS based on intestinal polyposis, osteomas, soft-tissue tumors, and histopathological criteria. Conclusion: This case underscores the critical role of multimodal imaging, histopathology, and MDT collaboration in clinical diagnosing GS with rare breast involvement. A systematic evaluation of extracolonic manifestations (e.g., adrenal adenomas) and the recognition of fibromatosis mimicking malignancy are essential for early diagnosis. Genetic evaluation and interdisciplinary management optimize the outcomes of complex hereditary syndromes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.